Table 3.
Chronic and acute white matter lesion volumes as predictors for APP metabolites in all patients.
| Dependent Variables | Independent variables p (beta) | ||
|---|---|---|---|
| cWML | aWML | Age | |
| CSF sAPP-α | ≤0.005 | n.s. | n.s. |
| (-0.396) | |||
| CSF sAPP-β | ≤0.01 | n.s. | n.s. |
| (-0.369) | |||
| CSF AβX-38 | ≤0.01 | n.s. | ≤0.01 |
| (-0.359) | (0.371) | ||
| CSF AβX-40 | ≤0.05 | n.s. | ≤0.05 |
| (-0.357) | (0.309) | ||
| CSF AβX-42 | ≤0.05 | n.s. | n.s. |
| (-0.273) | |||
Chronic WML significantly predicts CSF levels of APP metabolites.
cWML = chronic WML, aWML = acute WML.